Latest Articles

Publication Date
FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer - Pharmaceutical Executive

FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer Pharmaceutical Executive

Published: June 17, 2024, 7 a.m.
Interleukin-1β induces and accelerates human endometrial stromal cell senescence and impairs decidualization via the c-Jun N-terminal kinase pathway | Cell Death Discovery - Nature.com

Interleukin-1β induces and accelerates human endometrial stromal cell senescence and impairs decidualization via the c-Jun N-terminal kinase pathway | Cell Death Discovery Nature.com

Published: June 15, 2024, 7 a.m.
Adding Immunotherapy to Chemotherapy for Endometrial Cancer - Cleveland Clinic

Adding Immunotherapy to Chemotherapy for Endometrial Cancer Cleveland Clinic

Published: June 13, 2024, 7 a.m.
Corded and Hyalinized Endometrioid Endometrial Carcinoma: A Rare Case Treated With Robot-Assisted Surgery - Cureus

Corded and Hyalinized Endometrioid Endometrial Carcinoma: A Rare Case Treated With Robot-Assisted Surgery Cureus

Published: June 12, 2024, 7 a.m.
Upregulation of sperm-associated antigen 5 expression in endometrial carcinoma was associated with poor prognosis and immune dysregulation, and promoted cell migration and invasion - Nature.com

Upregulation of sperm-associated antigen 5 expression in endometrial carcinoma was associated with poor prognosis and immune dysregulation, and promoted cell migration and invasion Nature.com

Published: June 11, 2024, 7 a.m.
Abemaciclib Plus Fulvestrant Demonstrates Activity in Advanced Endometrial Cancer - Cancer Therapy Advisor

Abemaciclib Plus Fulvestrant Demonstrates Activity in Advanced Endometrial Cancer Cancer Therapy Advisor

Published: June 11, 2024, 7 a.m.
Weight Loss Drugs, Like Mounjaro, Taken By RHONJ Alum, May Reduce Endometrial Cancer Risk - SurvivorNet

Weight Loss Drugs, Like Mounjaro, Taken By RHONJ Alum, May Reduce Endometrial Cancer Risk SurvivorNet

Published: June 11, 2024, 7 a.m.
Study Misses Endpoints but Still Shows Benefit for Lenvatinib/Pembrolizumab in Endometrial Cancer Subsets - The ASCO Post

Study Misses Endpoints but Still Shows Benefit for Lenvatinib/Pembrolizumab in Endometrial Cancer Subsets The ASCO Post

Published: June 10, 2024, 7 a.m.
Endometriosis increases risks for ovarian, endometrial cancers - Healio

Endometriosis increases risks for ovarian, endometrial cancers Healio

Published: June 7, 2024, 7 a.m.
ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone - Medpage Today

ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone Medpage Today

Published: June 5, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!